Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection

David Ribet1,2,3, Valérie Lallemand-Breitenbach4,5, Omar Ferhi4,5

  • 1Institut Pasteur, Unité des Interactions Bactéries-Cellules, Paris, France.

Mbio
|January 12, 2017
PubMed

Insights

The promyelocytic leukemia protein (PML) restricts Listeria infection by regulating immunity genes and sensing bacterial toxins. PML

Area of Science:

  • Cellular Biology
  • Immunology
  • Microbiology

Background:

  • The promyelocytic leukemia protein (PML) organizes nuclear bodies and is crucial for cellular processes.
  • PML's role in antiviral defense is known, but its function in bacterial infection is unclear.
  • PML undergoes SUMOylation, a key posttranslational modification.

Purpose of the Study:

  • To investigate the role of PML in bacterial infection.
  • To elucidate the mechanisms by which PML restricts bacterial pathogens.
  • To identify PML-regulated immune responses against bacteria.

Main Methods:

  • Infection of host cells with Listeria monocytogenes and Salmonella enterica.
  • Analysis of PML modifications (oxidation, SUMOylation) during infection.
  • Transcriptomic and proteomic analyses to identify regulated genes.
  • Assays to assess bacterial intracellular multiplication.

Main Results:

  • PML restricts Listeria monocytogenes but not Salmonella enterica.
  • Listeria toxin LLO triggers PML de-SUMOylation and association with the nuclear matrix.
  • PML regulates a network of immunity genes and cytokines independently of LLO.
  • PML modification by pore-forming toxins acts as a danger signal, restricting bacterial growth.

Conclusions:

  • PML plays a dual role in antibacterial defense against Listeria.
  • PML senses bacterial pore-forming toxins, leading to restricted bacterial multiplication.
  • PML regulates immune gene expression in response to bacterial infection.
  • PML nuclear bodies dynamically regulate host defense mechanisms.